# Trial on Statins for Cirrhosis Won't End Debate Anytime Soon

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/meetingcoverage/aasld/123877) · 2026-11-13 · Medicine
Page: https://themorning.science/story/trial-on-statins-for-cirrhosis-won-t-end-debate-anytime-soon-9033bc72a8f653c5
Kind: research · Impact: medium

## In brief

- The phase III SACRED trial found statin therapy came close to, but did not reach, statistical significance in lowering risks of hepatic decompensation and liver cancer in patients with compensated cirrhosis.
- The primary result comes from an intention-to-treat analysis.
- MedPage Today's coverage was filed from the AASLD meeting and says the debate over statins in cirrhosis will continue.

## Why it matters

Statins are widely used for cardiovascular risk and are being studied as a possible way to slow cirrhosis complications, so a near-miss result leaves clinicians without a clear answer on whether to prescribe them to patients with compensated cirrhosis.

## Coverage

- [Trial on Statins for Cirrhosis Won't End Debate Anytime Soon](https://www.medpagetoday.com/meetingcoverage/aasld/123877) — MedPageToday.com - medical news for physicians, 2026-11-13

Tags: statins, cirrhosis, liver-disease, clinical-trial, liver-cancer

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science